Surgery Partners, Inc. (SGRY)
- Previous Close
25.38 - Open
25.25 - Bid 25.49 x 200
- Ask 25.55 x 100
- Day's Range
24.89 - 25.76 - 52 Week Range
22.05 - 45.79 - Volume
1,166,591 - Avg. Volume
921,354 - Market Cap (intraday)
3.228B - Beta (5Y Monthly) 2.74
- PE Ratio (TTM)
-- - EPS (TTM)
-0.09 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
42.36
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
www.surgerypartners.com10,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SGRY
Performance Overview: SGRY
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGRY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGRY
Valuation Measures
Market Cap
3.21B
Enterprise Value
6.08B
Trailing P/E
--
Forward P/E
22.88
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.16
Price/Book (mrq)
1.62
Enterprise Value/Revenue
2.22
Enterprise Value/EBITDA
13.63
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.43%
Return on Assets (ttm)
3.82%
Return on Equity (ttm)
4.07%
Revenue (ttm)
2.74B
Net Income Avi to Common (ttm)
-11.9M
Diluted EPS (ttm)
-0.09
Balance Sheet and Cash Flow
Total Cash (mrq)
195.9M
Total Debt/Equity (mrq)
91.60%
Levered Free Cash Flow (ttm)
142.69M